Oculus Secures FDA Clearance for Post-Dermal Device

Petaluma, Calif.-based Oculus Innovative Sciences has received FDA 510(k) premarket clearance for the company’s post-dermal-procedures device.

The device is intended to remove foreign material and debris after dermal procedures.

Oculus plans to market the device in the U.S. in March 2017. — José Vasquez